Effectiveness of VBP15, a dissociative steroidal analogue, on chronic inflammation in a mouse model of multiple sclerosis
Ended Project Grant Awarded Last action
- Award ID
- R41AI122780
- Recipient
-
Reveragen Biopharma, Inc. UEI NQA4J3L3E1Z4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $253,802
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Rockville, MD 20850, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $253,802 |
Quick answers
Who received award R41AI122780?
R41AI122780 was awarded to Reveragen Biopharma, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2016.
How much is award R41AI122780 worth?
$253,802 has been obligated on R41AI122780.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award